Research programme: anti-parathyroid hormone antagonists - Biotecnol/Universite Louis Pasteur/Strasbourg University
Latest Information Update: 14 Jun 2012
At a glance
- Originator Biotecnol Inc.; Universite Louis Pasteur de Strasbourg
- Developer Biotecnol Inc.; University of Strasbourg
- Class Antibodies
- Mechanism of Action Apoptosis stimulants; Parathyroid hormone receptor antagonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Renal cancer